Qualigen Therapeutics (QLGN) Financial Statements

Qualigen Therapeutics's market cap is currently ―. The company's EPS TTM is $-55.297; its P/E ratio is ―; Qualigen Therapeutics is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.